九强生物
(300406)
| 流通市值：69.00亿 | | | 总市值：95.66亿 |
| 流通股本：4.24亿 | | | 总股本：5.88亿 |
| 报告期 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,042,657,721.31 | 994,558,736.91 | 1,041,159,209.4 | 1,033,781,508.49 |
| 应收票据及应收账款 | 1,112,547,156.99 | 1,168,215,130.91 | 1,153,472,336.48 | 1,165,647,457.64 |
| 其中：应收票据 | 35,072,716.37 | 28,058,267.17 | 25,376,911.66 | 34,883,320.28 |
| 应收账款 | 1,077,474,440.62 | 1,140,156,863.74 | 1,128,095,424.82 | 1,130,764,137.36 |
| 预付款项 | 41,338,976.09 | 41,055,747.13 | 40,592,748.51 | 39,201,872.79 |
| 其他应收款合计 | 14,469,418.11 | 10,264,111.28 | 8,954,166.63 | 8,016,531.94 |
| 存货 | 220,680,889.1 | 236,177,735.01 | 225,477,890.77 | 236,851,457.39 |
| 一年内到期的非流动资产 | 140,374,619.02 | 144,975,759.58 | 132,550,963.88 | 257,330,530.4 |
| 其他流动资产 | 8,929,742.55 | 1,879,453.13 | 2,214,247.08 | 2,542,749.67 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,580,998,523.17 | 2,597,126,673.95 | 2,604,421,562.75 | 2,743,372,108.32 |
| 非流动资产: | | | | |
| 长期应收款 | 6,108,707 | 12,208,084.37 | 53,122,703.15 | 25,086,108.21 |
| 长期股权投资 | 29,459,835.04 | 30,509,467.49 | 30,999,624.4 | 31,929,317.95 |
| 其他权益工具投资 | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 |
| 投资性房地产 | 24,902,883.63 | 1,896,403.95 | - | - |
| 固定资产 | 574,699,602.41 | 608,073,796.47 | 620,348,773.42 | 618,889,325.58 |
| 在建工程 | - | 5,207,654.28 | 1,218,067.72 | 530,520.56 |
| 使用权资产 | 7,070,470.21 | 7,449,283.99 | 7,558,304.83 | 6,264,730.87 |
| 无形资产 | 57,083,536.49 | 58,731,379.6 | 59,405,719.21 | 58,435,381.14 |
| 商誉 | 1,672,545,682.47 | 1,672,545,682.47 | 1,672,545,682.47 | 1,672,545,682.47 |
| 长期待摊费用 | 1,915,904.39 | 1,854,026.76 | 1,920,990.14 | 2,065,574.75 |
| 递延所得税资产 | 48,367,909.24 | 48,279,767.86 | 48,350,767.25 | 45,922,666.24 |
| 其他非流动资产 | 541,812,108.3 | 383,284,691.67 | 168,784,691.67 | 43,060,691.67 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,993,966,639.18 | 2,860,040,238.91 | 2,694,255,324.26 | 2,534,729,999.44 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 5,574,965,162.35 | 5,457,166,912.86 | 5,298,676,887.01 | 5,278,102,107.76 |
| 流动负债: | | | | |
| 短期借款 | 105,861.99 | 39,300.44 | 241,108.12 | 63,881.75 |
| 应付票据及应付账款 | 69,285,738.53 | 93,440,536.78 | 96,015,886.63 | 99,717,277.78 |
| 其中：应付票据 | 1,185,923.33 | 17,316,769.83 | 4,356,748.33 | 15,491,904 |
| 应付账款 | 68,099,815.2 | 76,123,766.95 | 91,659,138.3 | 84,225,373.78 |
| 预收款项 | 7,052,582.87 | 8,077,511.55 | 3,061,091.1 | 4,404,875.3 |
| 合同负债 | 13,219,264.87 | 18,080,723.58 | 14,044,522.1 | 18,941,902.59 |
| 应付职工薪酬 | 64,953,052.45 | 49,373,549.25 | 31,076,692.11 | 14,967,907.48 |
| 应交税费 | 45,309,825.56 | 34,579,059.64 | 29,267,000.39 | 28,258,551.65 |
| 其他应付款合计 | 31,173,278.9 | 73,844,968.02 | 70,467,707.81 | 69,380,145.43 |
| 一年内到期的非流动负债 | 39,372,447.88 | 4,108,297.05 | 1,162,194.45 | 5,163,685.08 |
| 其他流动负债 | 7,657,555.5 | 6,044,535.48 | 6,023,288.25 | 6,684,422.02 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 278,129,608.55 | 287,588,481.79 | 251,359,490.96 | 247,582,649.08 |
| 非流动负债: | | | | |
| 长期借款 | 93,857,294.59 | 141,056,299.79 | 141,056,299.79 | 156,729,221.99 |
| 应付债券 | 1,029,672,563.85 | 1,020,599,386.7 | 1,011,666,665.53 | 1,001,965,884.56 |
| 租赁负债 | 5,245,330.92 | 5,552,609.22 | 6,237,522.09 | 4,810,169.33 |
| 递延收益 | 28,125,910.79 | 30,354,937.02 | 30,768,052.02 | 16,557,045.74 |
| 递延所得税负债 | 7,134,505.26 | 7,466,913.23 | 7,817,551.8 | 8,159,478.36 |
| 其他非流动负债 | - | 0 | - | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,164,035,605.41 | 1,205,030,145.96 | 1,197,546,091.23 | 1,188,221,799.98 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,442,165,213.96 | 1,492,618,627.75 | 1,448,905,582.19 | 1,435,804,449.06 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 588,326,491 | 588,446,367 | 588,446,253 | 588,446,253 |
| 其他权益工具 | 176,851,413.37 | 176,851,413.37 | 176,851,725.4 | 176,851,725.4 |
| 资本公积 | 382,471,002.9 | 409,058,033.9 | 412,178,535.38 | 404,126,799.74 |
| 减:库存股 | 93,631,150.59 | 128,362,274.04 | 123,884,244.57 | 111,275,919.72 |
| 其他综合收益 | 670,530.52 | 314,889.45 | 535,327.36 | 477,285.07 |
| 专项储备 | - | 0 | - | - |
| 盈余公积 | 294,163,245.5 | 288,671,652.74 | 288,671,652.74 | 280,464,487.72 |
| 一般风险准备 | - | 0 | - | - |
| 未分配利润 | 2,789,522,603.32 | 2,635,763,120.28 | 2,512,752,455.62 | 2,508,662,032.64 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 4,138,374,136.02 | 3,970,743,202.7 | 3,855,551,704.93 | 3,847,752,663.85 |
| 少数股东权益 | -5,574,187.63 | -6,194,917.59 | -5,780,400.11 | -5,455,005.15 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 4,132,799,948.39 | 3,964,548,285.11 | 3,849,771,304.82 | 3,842,297,658.7 |
| 负债和股东权益合计 | 5,574,965,162.35 | 5,457,166,912.86 | 5,298,676,887.01 | 5,278,102,107.76 |
| 公告日期 | 2025-03-29 | 2024-10-29 | 2024-08-23 | 2024-04-29 |
| 审计意见(境内) | 标准无保留意见 | | | |